HCA Healthcare
HCA
439.17
+6.97
+1.61%
HCA Healthcare
US · HCA
#238 by market cap
Listed 1970
439.17
+6.97
+1.61%
Live - 5344 symbols - heartbeat 559s ago
· 2026-10-08 06:24
Pre-market
439.55
+0.09%
After-hours
439.22
+0.01%
Overnight
439.17
0.00%
- Market cap
- 95.08B
- P/E (TTM)i
- 14.73
- P/Bi
- -14.32
- EPSi
- 28.33
- Div yieldi
- 0.68%
- 52W posi
- 43%
Reader sentiment
Are you bullish or bearish on HCA?
Anonymous reader poll. Unscientific, not investment advice.
Analyst consensus 22 analysts
Buy
Avg price target
456.50 +3.9%
Price target rangecurrent 439.17
Low380.00
Avg456.50
High579.00
Buy 64%
Hold 32%
Sell 5%
Recent ratings (25)
| Date | Firm | Analyst | Rating | Target |
|---|---|---|---|---|
| 2026-09-28 | Raymond James | -- | HOLD | -- |
| 2026-09-22 | BMO Capital | -- | BUY | 495.00 |
| 2026-09-17 | Jefferies | -- | BUY | 450.00 |
| 2026-09-17 | Leerink Partners | -- | BUY | -- |
| 2026-09-09 | Bernstein | -- | HOLD | 426.00 |
| 2026-09-07 | RBC Capital | -- | BUY | 435.00 |
| 2026-09-04 | Bernstein | -- | HOLD | 426.00 |
| 2026-09-01 | RBC Capital | -- | BUY | 435.00 |
| 2026-08-28 | Bernstein | -- | HOLD | 426.00 |
| 2026-08-20 | J.P. Morgan | -- | HOLD | 425.00 |
| 2026-08-14 | Bernstein | -- | HOLD | 426.00 |
| 2026-08-12 | Bernstein | -- | HOLD | 426.00 |
| 2026-08-10 | BofA Securities | -- | HOLD | 425.00 |
| 2026-08-07 | Argus Research | -- | BUY | 500.00 |
| 2026-08-05 | Truist Financial | -- | BUY | 495.00 |
| 2026-07-28 | Bernstein | -- | HOLD | 426.00 |
| 2026-07-28 | Mizuho Securities | -- | BUY | 475.00 |
| 2026-07-28 | Jefferies | -- | BUY | 450.00 |
| 2026-07-27 | TD Cowen | -- | BUY | 431.00 |
| 2026-07-27 | UBS | -- | BUY | 579.00 |
| 2026-07-27 | KeyBanc | -- | BUY | 435.00 |
| 2026-07-27 | Truist Financial | -- | BUY | 495.00 |
| 2026-07-27 | Baird | -- | HOLD | 393.00 |
| 2026-07-27 | Morgan Stanley | -- | SELL | 380.00 |
| 2026-07-27 | Deutsche Bank | -- | BUY | 476.00 |
Quant vs Street three independent views, side by side
StockVane factor grade
C+
Momentum strategy signal
Sell
Analyst consensus
Buy
Signals diverge - worth digging into why.
Not investment advice. The factor grade ranks this stock on fundamentals against StockVane's covered universe; the momentum strategy signal is a rules-based backtest, not a recommendation; analyst consensus reflects sell-side coverage. The three use different methods and can reasonably disagree.
Price target trend monthly average, last 3 years
✦ Quant Analyst Revision Trend how this is computed
Mixed
1 2
■ Upgrades■ Downgrades
- 1 upgrade vs 2 downgrades among tracked analyst rating changes.
- Most recent: BofA Securities moved from Buy to Hold on 2026-07-24.
Recent rating changes
| Date | Firm | Change | Target |
|---|---|---|---|
| 2026-07-24 | BofA Securities | BUY → HOLD | 400.00 |
| 2026-07-08 | Barclays | BUY → HOLD | 427.00 |
| 2026-07-08 | BofA Securities | HOLD → BUY | 435.00 |
Earnings history price reaction on the day
| Period | Report date | Session | Options expected | Actual move |
|---|---|---|---|---|
| 2026/Q2 | 2026-07-24 | -- | ±9.04% | +1.51% (in line) |
| 2026/Q1 | 2026-04-24 | -- | ±7.66% | -8.77% (beat) |
| 2025/Q4 | 2026-01-27 | -- | ±7.62% | +7.08% (in line) |
| 2025/Q3 | 2025-10-24 | -- | ±6.74% | +1.56% (in line) |
| 2025/Q2 | 2025-07-25 | -- | ±9.01% | -2.10% (in line) |
| 2025/Q1 | 2025-04-25 | -- | ±8.74% | -3.95% (in line) |
| 2024/Q4 | 2025-01-24 | -- | ±8.39% | -3.78% (in line) |
| 2024/Q3 | 2024-10-25 | -- | ±9.51% | -8.86% (in line) |
| 2024/Q2 | 2024-07-23 | -- | ±8.10% | +4.55% (in line) |
| 2024/Q1 | 2024-04-26 | -- | ±7.42% | -2.37% (in line) |
| 2023/Q4 | 2024-01-30 | -- | ±6.95% | +5.18% (in line) |
| 2023/Q3 | 2023-10-24 | -- | ±8.51% | -4.49% (in line) |
"Options expected" is the pre-earnings options market's implied move (a straddle-style estimate), shown next to what actually happened.
Quote time 2026-10-08 06:24:33 · For reference only, not investment advice and not tailored to your situation.